Literature DB >> 11752291

SELEX_DB: a database on in vitro selected oligomers adapted for recognizing natural sites and for analyzing both SNPs and site-directed mutagenesis data.

Julia V Ponomarenko1, Galina V Orlova, Anatoly S Frolov, Mikhail S Gelfand, Mikhail P Ponomarenko.   

Abstract

SELEX_DB is an online resource containing both the experimental data on in vitro selected DNA/RNA oligomers (aptamers) and the applets for recognition of these oligomers. Since in vitro experimental data are evidently system-dependent, the new release of the SELEX_DB has been supplemented by the database SYSTEM storing the experimental design. In addition, the recognition applet package, SELEX_TOOLS, applying in vitro selected data to annotation of the genome DNA, is accompanied by the cross-validation test database CROSS_TEST discriminating the sites (natural or other) related to in vitro selected sites out of random DNA. By cross-validation testing, we have unexpectedly observed that the recognition accuracy increases with the growth of homology between the training and test sets of protein binding sequences. For natural sites, the recognition accuracy was lower than that for the nearest protein homologs and higher than that for distant homologs and non-homologous proteins binding the common site. The current SELEX_DB release is available at http://wwwmgs.bionet.nsc.ru/mgs/systems/selex/.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752291      PMCID: PMC99084          DOI: 10.1093/nar/30.1.195

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  14 in total

1.  SELEX_DB: an activated database on selected randomized DNA/RNA sequences addressed to genomic sequence annotation.

Authors:  J V Ponomarenko; G V Orlova; M P Ponomarenko; S V Lavryushev; A S Frolov; S V Zybova; N A Kolchanov
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  ACTIVITY: a database on DNA/RNA sites activity adapted to apply sequence-activity relationships from one system to another.

Authors:  J V Ponomarenko; D P Furman; A S Frolov; N L Podkolodny; G V Orlova; M P Ponomarenko; N A Kolchanov; A Sarai
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

3.  rSNP_Guide, a database system for analysis of transcription factor binding to target sequences: application to SNPs and site-directed mutations.

Authors:  J V Ponomarenko; T I Merkulova; G V Vasiliev; Z B Levashova; G V Orlova; S V Lavryushev; O N Fokin; M P Ponomarenko; A S Frolov; A Sarai
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

4.  Single-nucleotide polymorphisms in the public domain: how useful are they?

Authors:  G Marth; R Yeh; M Minton; R Donaldson; Q Li; S Duan; R Davenport; R D Miller; P Y Kwok
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

5.  DNA binding sites for the transcriptional activator/repressor YY1.

Authors:  R P Hyde-DeRuyscher; E Jennings; T Shenk
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

6.  Cloning and characterization of the 5'-flanking region for the human topoisomerase III gene.

Authors:  J C Kim; J B Yoon; H S Koo; I K Chung
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

7.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms.

Authors:  R Sachidanandam; D Weissman; S C Schmidt; J M Kakol; L D Stein; G Marth; S Sherry; J C Mullikin; B J Mortimore; D L Willey; S E Hunt; C G Cole; P C Coggill; C M Rice; Z Ning; J Rogers; D R Bentley; P Y Kwok; E R Mardis; R T Yeh; B Schultz; L Cook; R Davenport; M Dante; L Fulton; L Hillier; R H Waterston; J D McPherson; B Gilman; S Schaffner; W J Van Etten; D Reich; J Higgins; M J Daly; B Blumenstiel; J Baldwin; N Stange-Thomann; M C Zody; L Linton; E S Lander; D Altshuler
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

8.  Extension of the DNA binding consensus of the chicken c-Myb and v-Myb proteins.

Authors:  K Weston
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

9.  Using sequence logos and information analysis of Lrp DNA binding sites to investigate discrepancies between natural selection and SELEX.

Authors:  R K Shultzaberger; T D Schneider
Journal:  Nucleic Acids Res       Date:  1999-02-01       Impact factor: 16.971

10.  A comprehensive library of DNA-binding site matrices for 55 proteins applied to the complete Escherichia coli K-12 genome.

Authors:  K Robison; A M McGuire; G M Church
Journal:  J Mol Biol       Date:  1998-11-27       Impact factor: 5.469

View more
  12 in total

1.  Aptamer database.

Authors:  Jennifer F Lee; Jay R Hesselberth; Lauren Ancel Meyers; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Regulatory single nucleotide polymorphisms at the beginning of intron 2 of the human KRAS gene.

Authors:  Elena V Antontseva; Marina Yu Matveeva; Natalia P Bondar; Elena V Kashina; Elena Yu Leberfarb; Leonid O Bryzgalov; Polina A Gervas; Anastasia A Ponomareva; Nadezhda V Cherdyntseva; Yury L Orlov; Tatiana I Merkulova
Journal:  J Biosci       Date:  2015-12       Impact factor: 1.826

Review 3.  Analysis of In Vitro Aptamer Selection Parameters.

Authors:  Maureen McKeague; Erin M McConnell; Jose Cruz-Toledo; Elyse D Bernard; Amanda Pach; Emily Mastronardi; Xueru Zhang; Michael Beking; Tariq Francis; Amanda Giamberardino; Ashley Cabecinha; Annamaria Ruscito; Rocio Aranda-Rodriguez; Michel Dumontier; Maria C DeRosa
Journal:  J Mol Evol       Date:  2015-11-03       Impact factor: 2.395

4.  Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Mikhail P Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Marina Yu Matveeva; Tatjana V Arshinova; Petr M Ponomarenko; Olga V Arkova; Natalia P Bondar; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

5.  Aptamer Base: a collaborative knowledge base to describe aptamers and SELEX experiments.

Authors:  Jose Cruz-Toledo; Maureen McKeague; Xueru Zhang; Amanda Giamberardino; Erin McConnell; Tariq Francis; Maria C DeRosa; Michel Dumontier
Journal:  Database (Oxford)       Date:  2012-03-20       Impact factor: 3.451

6.  RiboaptDB: a comprehensive database of ribozymes and aptamers.

Authors:  Venkata Thodima; Mehdi Pirooznia; Youping Deng
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

Review 7.  Finding signals that regulate alternative splicing in the post-genomic era.

Authors:  Andrea N Ladd; Thomas A Cooper
Journal:  Genome Biol       Date:  2002-10-23       Impact factor: 13.583

8.  How to Use SNP_TATA_Comparator to Find a Significant Change in Gene Expression Caused by the Regulatory SNP of This Gene's Promoter via a Change in Affinity of the TATA-Binding Protein for This Promoter.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Olga Arkova; Petr Ponomarenko; Valentin Suslov; Ludmila Savinkova; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

9.  Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters.

Authors:  Olga V Arkova; Mikhail P Ponomarenko; Dmitry A Rasskazov; Irina A Drachkova; Tatjana V Arshinova; Petr M Ponomarenko; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2015-12-16       Impact factor: 3.969

10.  Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Dmitry Rasskazov; Valentin Suslov; Ekaterina Sharypova; Ludmila Savinkova; Olga Podkolodnaya; Nikolay L Podkolodny; Natalya N Tverdokhleb; Irina Chadaeva; Mikhail Ponomarenko; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2016-08-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.